Source: centralcharts

Press Release: NeoGenomics : NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO), a leading oncology testing services company, today announced the Company will

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
Tony Zook's photo - CEO of NeoGenomics

CEO

Tony Zook

CEO Approval Rating

82/100

Read more